PFN2 and small cell lung carcinoma: In SCLC, lncRNA LYPLAL1‐DT acts as an oncogenic lncRNA, which negatively regulates miR‐204‐5p leading to the upregulation of PFN2, promoting cell proliferation, migration and invasion [63].